Yi-Hsiang Huang
National Taiwan University
H-index: 59
Asia-Taiwan
Top articles of Yi-Hsiang Huang
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan | Hepatology International | Ming-Lung Yu Chi‐Ming Tai Lein-Ray Mo Hsing-Tao Kuo Chung-Feng Huang | 2024/1/21 |
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program | Clinical and molecular hepatology | Ming-Ying Lu Chung-Feng Huang Chao-Hung Hung Chi‐Ming Tai Lein-Ray Mo | 2024/1 |
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours | Journal of Hepatology | Ciro Celsa Giuseppe Cabibbo Claudia AM Fulgenzi Bernhard Scheiner Antonio D’Alessio | 2024/3/1 |
Identification of factors associated with primary refractoriness to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma | Digestive and Liver Disease | GF Manfredi CAM Fulgenzi A D'Alessio C Celsa B Stefanini | 2024/2/1 |
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma | JHEP reports | Lorenz Balcar Bernhard Scheiner Claudia Angela Maria Fulgenzi Antonio D’Alessio Katharina Pomej | 2024/2/1 |
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors | Frontiers in oncology | Y Linda Wu Grace van Hyfte Umut Özbek Marlene Reincke Anuhya Gampa | 2023/2/14 |
Efficacy and tolerability of atezolizumab and bevacizumab in patients with hepatocellular carcinoma previously treated with systemic therapy | Age | Vincent Jörg Bernhard Scheiner Antonio DAlessio Claudia AM Fulgenzi Martin Schoenlein | 2023/6/1 |
Floating image display device | 2023/9/14 | ||
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial | The Lancet Oncology | Josep M Llovet Masatoshi Kudo Philippe Merle Tim Meyer Shukui Qin | 2023/12/1 |
Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers in unresectable hepatocellular carcinoma (HCC) treated with atezolizumab … | Annals of Oncology | S Rafee DJ McHugh M Greally O Ayodele N Keegan | 2016/10/1 |
19‐2: A Novel 3D Floating Image for Human‐Machine Interfaces and Its Application | SID Symposium Digest of Technical Papers | Yi-Hsiang Huang Kuan-Ting Chen Hung Tsou Szu-Wei Wu Chia-Ping Lin | 2023/6 |
Space three-dimensional imaging apparatus and method | 2023/8/22 | ||
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label … | The Lancet | Shukui Qin Minshan Chen Ann-Lii Cheng Ahmed O Kaseb Masatoshi Kudo | 2023/11/18 |
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan | Journal of Hepatology | Pei-Chien Tsai Hsing-Tao Kuo Chao-Hung Hung Kuo-Chih Tseng Hsueh-Chou Lai | 2023/2/1 |
Device and method for generating floating image | 2023/3/28 | ||
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma | Hepatology international | Mathew Vithayathil Antonio D’Alessio Claudia Angela Maria Fulgenzi Naoshi Nishida Martin Schönlein | 2023/8 |
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma | World journal of gastrointestinal oncology | Sirish Dharmapuri Umut Özbek Hiren Jethra Tomi Jun Thomas U Marron | 2023/11/11 |
Switchable floating image display device | 2023/12/12 | ||
Real-world dosing of regorafenib in patients with unresectable hepatocellular carcinoma (uHCC): Final analysis of the prospective, observational REFINE study. | Richard S Finn Philippe Merle Masafumi Ikeda Heinz-Josef Klümpen Gianluca Masi | 2023/2/1 | |
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir-vs. entecavir-based regimens: Individual patient data meta-analysis | Journal of hepatology | Won-Mook Choi Terry Cheuk-Fung Yip Grace Lai-Hung Wong W Ray Kim Leland J Yee | 2023/3/1 |
Co-Authors
